Burgess W H, Shaheen A M, Ravera M, Jaye M, Donohue P J, Winkles J A
Laboratory of Molecular Biology, Jerome H. Holland Laboratory for the Biomedical Sciences, American Red Cross, Rockville, Maryland 20855.
J Cell Biol. 1990 Nov;111(5 Pt 1):2129-38. doi: 10.1083/jcb.111.5.2129.
The fibroblast or heparin-binding growth factors (HBGFs) are thought to be modulators of cell growth and migration, angiogenesis, wound repair, neurite extension, and mesoderm induction. A better understanding of the structural basis for the different activities of these proteins should facilitate the development of agonists and antagonists of specific HBGF activities and identification of the signal transduction pathways involved in the mechanisms of action of these growth factors. Chemical modification studies of Harper and Lobb (Harper, J. W., and R. R. Lobb. 1988. Biochemistry. 27:671-678) implicated lysine 132 in HBGF-1 (acidic fibroblast growth factor) as being important to the heparin-binding, receptor-binding, and mitogenic activities of the protein. We changed lysine 132 to a glutamic acid residue by site-directed mutagenesis of the human cDNA and expressed the mutant protein in Escherichia coli to obtain sufficient quantities for functional studies. Replacement of this lysine with glutamic acid reduces the apparent affinity of HBGF-1 for immobilized heparin (elutes at 0.45 M NaCl vs. 1.1 M NaCl for wild-type). Mitogenic assays established two points: (a) human recombinant HBGF-1 is highly dependent on the presence of heparin for optimal mitogenic activity, and (b) the change of lysine 132 to glutamic acid drastically reduces the specific mitogenic activity of HBGF-1. The poor mitogenic activity of the mutant protein does not appear to be due to a reduced affinity for the HBGF receptor. Similarly, the mutant HBGF-1 can stimulate tyrosine kinase activity and induce protooncogene expression. Differences in the biological properties of the wild-type and mutant proteins were observed in transfection studies. Mutant HBGF-1 expression in transfected NIH 3T3 cells did not induce the same transformed phenotype characteristic of cells expressing wild-type HBGF-1. Together these data indicate that different functional properties of HBGF-1 may be dissociated at the structural level.
成纤维细胞生长因子或肝素结合生长因子(HBGFs)被认为是细胞生长与迁移、血管生成、伤口修复、神经突延伸及中胚层诱导的调节因子。更好地理解这些蛋白质不同活性的结构基础,应有助于开发特定HBGF活性的激动剂和拮抗剂,并确定参与这些生长因子作用机制的信号转导途径。哈珀和洛布的化学修饰研究(哈珀,J.W.,和R.R.洛布。1988年。生物化学。27:671 - 678)表明,HBGF - 1(酸性成纤维细胞生长因子)中的赖氨酸132对该蛋白质的肝素结合、受体结合及促有丝分裂活性很重要。我们通过对人cDNA进行定点诱变,将赖氨酸132替换为谷氨酸残基,并在大肠杆菌中表达突变蛋白,以获得足够量用于功能研究。用谷氨酸取代该赖氨酸会降低HBGF - 1对固定化肝素的表观亲和力(在0.45M NaCl时洗脱,而野生型在1.1M NaCl时洗脱)。促有丝分裂试验确定了两点:(a)人重组HBGF - 1的最佳促有丝分裂活性高度依赖于肝素的存在;(b)赖氨酸132变为谷氨酸会大幅降低HBGF - 1的特异性促有丝分裂活性。突变蛋白促有丝分裂活性差似乎并非由于对HBGF受体的亲和力降低。同样,突变型HBGF - 1可刺激酪氨酸激酶活性并诱导原癌基因表达。在转染研究中观察到野生型和突变型蛋白生物学特性的差异。转染的NIH 3T3细胞中突变型HBGF - 1的表达并未诱导出表达野生型HBGF - 1的细胞所特有的相同转化表型。这些数据共同表明,HBGF - 1的不同功能特性在结构水平上可能是分离的。